Cyclosporine A (CsA) is an immunosuppressive drug that is widely used after organ transplantation and in the treatment of autoimmune diseases. However, CsA-treatment produces a secondary hypertension that contributes to the morbidity and mortality of organ transplant patients. CsA-induced hypertension is mediated by afferent renal nerves (ARN), but the central neural circuitry mediating CsA-induced hypertension is unknown. Here, the neural circuitry that is activated by CsA-induced hypertension will be determined. My overall hypothesis is that CsA activates renal chemoreceptors.
Aim I. Determine the neural pathways activated by CsA. Activated neurons will be identified by immunocytochemical staining for the phosphorylated form of cyclic AMP response element binding protein (pCREB). The advantage that pCREB has over fos staining is that pCREB staining is found in activated first-order neurons.
Aim I 1. Determine whether renal afferent pathways are organized topographically within the dorsal horn. To address this aim, the location of pCREB-stained neurons will be serially reconstructed after CsA, mechano- or chemoreceptor activation and ureteral ligation.
Aim III. Determine the neurotransmitters used by first-order sensory neurons activated by CsA, mechano- or chemoreceptor activation and ureteral ligation by double staining immunocytochemistry. It is predicted that the activated dorsal horn neurons are differentially distributed within the spinal cord and that distinct neurotransmitters are used by the specific functional types of renal afferents. The overall hypothesis will be evaluated by comparing the distribution of pCREB-stained neurons within the spinal segment and by comparing the neurotransmitter phenotype of pCREB-labeled first-order neurons after CsA, mechano- or chemoreceptor activation and uretral ligation. Our understanding of renal afferent pathways and the neural circuitry that is associated with CsA-induced hypertension is limited; a better understanding of these pathways will permit targeted interventions in the future.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS034160-05A2
Application #
6732229
Study Section
Cardiovascular and Renal Study Section (CVB)
Program Officer
Mitler, Merrill
Project Start
1997-01-15
Project End
2007-09-29
Budget Start
2003-09-30
Budget End
2004-09-29
Support Year
5
Fiscal Year
2003
Total Cost
$270,100
Indirect Cost
Name
Kansas State University
Department
Anatomy/Cell Biology
Type
Schools of Veterinary Medicine
DUNS #
929773554
City
Manhattan
State
KS
Country
United States
Zip Code
66506
López, Yelica; Lutjemeier, Barbara; Seshareddy, Kiran et al. (2013) Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report. Curr Stem Cell Res Ther 8:46-59
Hong, James; He, Hong; Bui, Phuoc et al. (2013) A focused microarray for screening rat embryonic stem cell lines. Stem Cells Dev 22:431-43
McGuirk, J P; Weiss, M L (2011) Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review). Placenta 32 Suppl 4:S304-10
Ferrer, M S; Lutjemeier, B J; Koopman, T et al. (2011) Xenogeneic transplantation of equine testicular cells into seminiferous tubules of immunocompetent rats. Theriogenology 75:1258-64
Parolini, O; Alviano, F; Betz, A G et al. (2011) Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). Placenta 32 Suppl 4:S285-90
Wang, Limin; Ott, Lindsey; Seshareddy, Kiran et al. (2011) Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med 6:95-109
Hong, James; He, Hong; Weiss, Mark L (2011) Derivation and Characterization of Embryonic Stem Cells Lines Derived from Transgenic Fischer 344 and Dark Agouti Rats. Stem Cells Dev :
He, Hong; McHaney, Mark; Hong, James et al. (2009) Cloning and Characterization of 3.1kb Promoter Region of the Oct4 Gene from the Fischer 344 Rat. Open Stem Cell J 1:30-39
Rachakatla, Raja Shekar; Pyle, Marla M; Ayuzawa, Rie et al. (2008) Combination treatment of human umbilical cord matrix stem cell-based interferon-beta gene therapy and 5-fluorouracil significantly reduces growth of metastatic human breast cancer in SCID mouse lungs. Cancer Invest 26:662-70
Troyer, Deryl L; Weiss, Mark L (2008) Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 26:591-9

Showing the most recent 10 out of 28 publications